Cardiac disease in pregnancy overview
Cardiac disease in pregnancy Microchapters |
Diagnosis |
---|
Catheterization: |
Treatment |
Special Scenarios:
|
Cardiac disease in pregnancy overview On the Web |
American Roentgen Ray Society Images of Cardiac disease in pregnancy overview |
Directions to Hospitals Treating Cardiac disease in pregnancy |
Risk calculators and risk factors for Cardiac disease in pregnancy overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Anjan K. Chakrabarti, M.D. [2]
Overview
Approximately 1-4% of pregnancies in the United States occur in women with maternal cardiovascular disease. In fact, pregnancy can "unmask" underlying cardiovascular disease, due to the hemodynamic changes associated with pregnancy. [1] With a careful pre-pregnancy evaluation, most women with cardiovascular disease can carry a pregnancy to term with proper care.
Epidemiology and Demographics
Increasing numbers of women with congenital heart disease are now reaching childbearing age, making congenital heart disease the most common form of heart disease complicating pregnancy in the United States. Rheumatic heart disease is still prevalent in the developing world and in immigrant populations. Overall, maternal death during pregnancy in women with heart disease is rare, but certain conditions are associated with an increased mortality.[2]
Disorders Associated with Cardiovascular Disease in Pregnancy
Maternal cardiovascular disease includes (most commonly) congenital heart disease. Other cardiovascular disorders encountered during pregnancy include cardiomyopathies, both dilated and hypertrophic, and valvular heart disease, such as bicuspid aortic valve and mitral valve prolapse. Less common cardiovascular disorders include pulmonary hypertension and, rarely, coronary artery disease. The above cardiovascular disorders require a strategy regarding the frequency of follow-up by the cardiologist and a plan for labor and delivery.[3]
Risk Factors
The following clinical characteristics are independent predictors of adverse outcomes in a risk score for maternal cardiac complications[4]:
- Prior cardiac events or arrhythmia
- Poor functional class or cyanosis
- Left ventricular outflow tract obstruction
- Left ventricular systolic dysfunction
Pulmonary hypertension is a well recognized risk factor during maternal pregnancy. In particular the presence of Eisenmenger syndrome places the mother particularly high risk.
Diagnosis
History and Symptoms
Common symptoms present during pregnancy include: fatigue, decreased exercise capacity, hyperventilation, dyspnea, tachycardia and palpitations.
Secondary to inferior vena caval compression by the gravid uterus resulting in reduced venous return from the lower extremities, patients may even experience orthostatic lightheadedness and syncope.
Pedal edema is often observed during the last trimester and may lead to an erroneous diagnosis of heart failure.
Physical Examination
Significant similarities exist between the normal signs of pregnancy and the presence of an underlying cardiac disease; hence poses a clinical challenge to differentiate between the two. However, common signs include: jugular venous distension, pulmonary rales, increased intensity of heart sounds and pedal edema.
ECG
The common electrocardiographic findings that occur secondary to physiological changes during pregnancy include: tachycardia, short PR interval and left axis deviation.
Echocardiography
Echocardiograhy does not carry the risk of fetal irradiation; hence, is a safe and preferred screening method to assess cardiac function and valvular lesions.
Chest X Ray
Routine chest x-ray is avoided, especially in the first trimester.
Chest x-ray in normal pregnancy may reveal physiologic changes such as increased left ventricular dimension and cardiomegaly, which in the absence of dyspnea is secondary to the elevation of diaphragm and should be interpreted with caution.
Among patients with dyspnea, chest x-ray in done to identify the presence of heart failure, which may show cardiomegaly, Kerley B lines, pleural effusion and cephalization of blood vessels.
MRI
No known safety hazards are observed with MRI, especially after first trimester.[5] However, the experience with this technique is limited and is indicated only when other imaging modalities such chest x-ray and echocardiography are inconclusive or to identify aortic diseases in pregnancy.[6] Currently, the FDA recommends prudent use of MRI during pregnancy.
Contrast MRI using gadolinium is contraindicated as gadolinium crosses the trans-placental membrane and exposes the fetus to teratogenicity.
CT
The preferable estimated fetal exposure from ionizing radiation should be below 50 mGy and with CT, the exposed radiation is 0.3 mGy and therefore contra-indicated during pregnancy.[7]
The only exception for the use of CT during pregnancy include to diagnosis pulmonary embolism, for which a low-radiation CT is recommended.[8][9]
Treatment
References
- ↑ Roos-Hesselink JW, Duvekot JJ, Thorne SA (2009). "Pregnancy in high risk cardiac conditions". Heart. 95 (8): 680–6. doi:10.1136/hrt.2008.148932. PMID 19329725.
- ↑ Siu SC, Colman JM (2001). "Heart disease and pregnancy". Heart. 85 (6): 710–5. PMC 1729784. PMID 11359761.
- ↑ Thorne SA (2004). "Pregnancy in heart disease". Heart. 90 (4): 450–6. PMC 1768170. PMID 15020530.
- ↑ Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC; et al. (2001). "Prospective multicenter study of pregnancy outcomes in women with heart disease". Circulation. 104 (5): 515–21. PMID 11479246.
- ↑ De Wilde JP, Rivers AW, Price DL (2005). "A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus". Progress in Biophysics and Molecular Biology. 87 (2–3): 335–53. doi:10.1016/j.pbiomolbio.2004.08.010. PMID 15556670. Retrieved 2012-04-18.
- ↑ Shellock FG, Crues JV (2004). "MR procedures: biologic effects, safety, and patient care". Radiology. 232 (3): 635–52. doi:10.1148/radiol.2323030830. PMID 15284433. Retrieved 2012-04-18. Unknown parameter
|month=
ignored (help) - ↑ van Hoeven KH, Kitsis RN, Katz SD, Factor SM (1993). "Peripartum versus idiopathic dilated cardiomyopathy in young women--a comparison of clinical, pathologic and prognostic features". International Journal of Cardiology. 40 (1): 57–65. PMID 8349367. Unknown parameter
|month=
ignored (help);|access-date=
requires|url=
(help) - ↑ Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP (2008). "Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)". European Heart Journal. 29 (18): 2276–315. doi:10.1093/eurheartj/ehn310. PMID 18757870. Retrieved 2012-04-18. Unknown parameter
|month=
ignored (help) - ↑ Winer-Muram HT, Boone JM, Brown HL, Jennings SG, Mabie WC, Lombardo GT (2002). "Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT". Radiology. 224 (2): 487–92. PMID 12147847. Retrieved 2012-04-18. Unknown parameter
|month=
ignored (help)